Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 52 results.
User Information
Export Records
  1. 1.   Development of a bicistronic anti-CD19/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions
  2. Lam, Norris; Finney, Richard; Yang, Shicheng; Choi, Stephanie; Wu,Xiaolin; Cutmore, Lauren; Andrade, Jorge; Huang, Lei; Amatya, Christina; Cam, Margaret; Kochenderfer, James N
  3. Molecular Therapy Oncolytics. 2023, Sep 21; 30: 132-149.
  1. 2.   Dual B-cell targeting therapy ameliorates autoimmune cholangitis
  2. Zhang, Weici; Shao, Tihong; Leung, Patrick S C; Tsuneyama, Koichi; Heuer, Luke; Young,Howard; Ridgway, William M; Gershwin, M Eric
  3. Journal of Autoimmunity. 2022, Aug 24; 132: 102897.
  1. 3.   Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer
  2. Zeligs, Kristen P.; Morelli, Maria Pia; David, Justin M.; Neuman, Monica; Hernandez, Lidia; Hewitt, Stephen; Ozaki, Michelle; Osei-Tutu, Akosua; Anderson, David; Andresson,Thorkell; Das,Sudipto; Lack,Justin; Abdelmaksoud,Abdalla; Fantini, Massimo; Arlen, Philip M.; Tsang, Kwong Y.; Annunziata, Christina M.
  3. FRONTIERS IN ONCOLOGY. 2020, JUN 19; 10: 805.
  1. 4.   IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody
  2. Richardson, Simone I; Lambson, Bronwen E; Crowley, Andrew R; Bashirova,Arman; Scheepers, Cathrine; Garrett, Nigel; Abdool Karim, Salim; Mkhize, Nonhlanhla N; Carrington,Mary; Ackerman, Margaret E; Moore, Penny L; Morris, Lynn
  3. PLoS pathogens. 2019, Dec 16; 15(12): e1008064.
  1. 5.   Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies
  2. Dobrovolskaia,Marina
  3. Molecules (Basel, Switzerland). 2019, Dec; 24(24):
  1. 6.   IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
  2. Kerkar, S. P.; Goldszmid, R. S.; Muranski, P.; Chinnasamy, D.; Yu, Z. Y.; Reger, R. N.; Leonardi, A. J.; Morgan, R. A.; Wang, E.; Marincola, F. M.; Trinchieri, G.; Rosenberg, S. A.; Restifo, N. P.
  3. Journal of Clinical Investigation. 2011, Dec; 121(12): 4746-4757.
  1. 7.   The split personality of NKT cells in malignancy, autoimmune and allergic disorders
  2. Subleski, J. J.; Jiang, Q.; Weiss, J. M.; Wiltrout, R. H.
  3. Immunotherapy. 2011, Oct; 3(10): 1167-1184.
  1. 8.   KIR2DL2 Enhances Protective and Detrimental HLA Class I-Mediated Immunity in Chronic Viral Infection
  2. al Basatena, N. K. S.; MacNamara, A.; Vine, A. M.; Thio, C. L.; Astemborski, J.; Usuku, K.; Osame, M.; Kirk, G. D.; Donfield, S. M.; Goedert, J. J.; Bangham, C. R. M.; Carrington, M.; Khakoo, S. I.; Asquith, B.
  3. Plos Pathogens. 2011, Oct; 7(10): 12.
  1. 9.   Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system?
  2. Reizis, B.; Colonna, M.; Trinchieri, G.; Barrat, F.; Gilliet, M.
  3. Nature Reviews Immunology. 2011, Aug; 11(8): 558-U82.
  1. 10.   FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer
  2. Watkins, S. K.; Zhu, Z. Q.; Riboldi, E.; Shafer-Weaver, K. A.; Stagliano, K. E. R.; Sklavos, M. M.; Ambs, S.; Yagita, H.; Hurwitz, A. A.
  3. Journal of Clinical Investigation. 2011, Apr; 121(4): 1361-1372.
  1. 11.   Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy
  2. Barsov, E. V.
  3. Immunotherapy. 2011, Mar; 3(3): 407-421.
  1. 12.   HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
  2. McCormack, M.; Alfirevic, A.; Bourgeois, S.; Farrell, J. J.; Kasperaviciute, D.; Carrington, M.; Sills, G. J.; Marson, T.; Jia, X. M.; de Bakker, P. I. W.; Chinthapalli, K.; Molokhia, M.; Johnson, M. R.; O'Connor, G. D.; Chaila, E.; Alhusaini, S.; Shianna, K. V.; Radtke, R. A.; Heinzen, E. L.; Walley, N.; Pandolfo, M.; Pichler, W.; Park, B. K.; Depondt, C.; Sisodiya, S. M.; Goldstein, D. B.; Deloukas, P.; Delanty, N.; Cavalleri, G. L.; Pirmohamed, M.
  3. New England Journal of Medicine. 2011, Mar; 364(12): 1134-1143.
  1. 13.   Multidimensional glycan arrays for enhanced antibody profiling
  2. Zhang, Y. L.; Campbell, C.; Li, Q. A.; Gildersleeve, J. C.
  3. Molecular Biosystems. 2010, Sep; 6(9): 1583-1591.
  1. 14.   Alternatively Activated and Immunoregulatory Monocytes in Human Filarial Infections
  2. Babu, S.; Kumaraswami, V.; Nutman, T. B.
  3. Journal of Infectious Diseases. 2009 199(12): 1827-1837.
  1. 15.   A Central Role for Transcription Factor C/EBP-beta in Regulating CD1d Gene Expression in Human Keratinocytes
  2. Sikder, H.; Zhao, Y.; Balato, A.; Chapoval, A.; Fishelevich, R.; Gade, P.; Singh, I. S.; Kalvakolanu, D. V.; Johnson, P. F.; Gaspari, A. A.
  3. Journal of Immunology. 2009 183(3): 1657-1666.
  1. 16.   Upregulation of CTLA-4 by HIV-specific CD4(+) T cells correlates with disease progression and defines a reversible immune dysfunction
  2. Kaufmann, D. E.; Kavanagh, D. G.; Pereyra, F.; Zaunders, J. J.; Mackey, E. W.; Miura, T.; Palmer, S.; Brockman, M.; Rathod, A.; Piechocka-Trocha, A.; Baker, B.; Zhu, B.; Le Gall, S.; Waring, M. T.; Ahern, R.; Moss, K.; Kelleher, A. D.; Coffin, J. M.; Freeman, G. J.; Rosenberg, E. S.; Walker, B. D.
  3. Nature Immunology. 2007, Nov; 8(11): 1246-1254.
  1. 17.   Potential of transfected muscle cells to contribute to DNA vaccine immunogenicity
  2. Shirota, H.; Petrenko, L.; Hong, C.; Klinman, D. M.
  3. Journal of Immunology. 2007, Jul; 179(1): 329-336.
  1. 18.   Comparative genomic structure of human, dog, and cat MHC: HLA, DLA, and FLA
  2. Yuhki, N.; Beck, T.; Stephens, R.; Neelam, B.; O'Brien, S. J.
  3. Journal of Heredity. 2007 98(5): 390-399.
  1. 19.   CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques
  2. Hryniewicz, A.; Boasso, A.; Edghill-Smith, Y.; Vaccari, M.; Fuchs, D.; Venzon, D.; Nacsa, J.; Betts, M. R.; Tsai, W. P.; Heraud, J. M.; Beer, B.; Blanset, D.; Chougnet, C.; Lowy, I.; Shearer, G. M.; Franchini, G.
  3. Blood. 2006, Dec; 108(12): 3834-3842.
  1. 20.   Macaque multimeric soluble CD40 ligand and GITR ligand constructs are immunostimulatory molecules in vitro
  2. Stone, G. W.; Barzee, S.; Snarsky, V.; Spina, C. A.; Lifson, J. D.; Pillai, V. K. B.; Amara, R. R.; Villinger, F.; Kornbluth, R. S.
  3. Clinical and Vaccine Immunology. 2006, Nov; 13(11): 1223-1230.
  1. 21.   Fra-1 a target for cancer prevention or intervention
  2. Young, M. R.; Colburn, N. H.
  3. Gene. 2006, Sep; 379: 1-11.
  1. 22.   Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis
  2. Francesconi, A.; Kasai, M.; Petraitiene, R.; Petraitis, V.; Kelaher, A. M.; Schaufele, R.; Hope, W. W.; Shea, Y. R.; Bacher, J.; Walsh, T. J.
  3. Journal of Clinical Microbiology. 2006, Jul; 44(7): 2475-2480.
  1. 23.   Capture of antigen-specific T lymphocytes from human blood by selective immortalization to establish long-term T-cell lines maintaining primary cell characteristics
  2. Barsov, E. V.; Andersen, H.; Coalter, V. J.; Carrington, M.; Lifson, J. D.; Ott, D. E.
  3. Immunology Letters. 2006, May; 105(1): 26-37.
  1. 24.   Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine
  2. Garcia-Pineres, A. J.; Hildesheim, A.; Trivett, M.; Williams, M.; Wu, L.; KewalRamani, V. N.; Pinto, L. A.
  3. European Journal of Immunology. 2006, Feb; 36(2): 437-445.
  1. 25.   Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody
  2. Fuss, I. J.; Becker, C.; Yang, Z. Q.; Groden, C.; Hornung, R. L.; Heller, F.; Neurath, M. F.; Strober, W.; Mannon, P. J.
  3. Inflammatory Bowel Diseases. 2006, JAN; 12(1): 9-15.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel